Magnitude of Community Acquired Pneumonia among Hospital treated Adults in Tikur Anbessa Specialized Hospital: A Hospital Based Retrospective Study.
Keywords:Magnitude, CAP, hospital
Pneumonia is a major cause of morbiddity and mortaiity in low and middel income countries.The aim of this study was to determin the magnitude of community acquired pneumonia(CAP) among hospital treated adult patients at Tikur Anbessa Specilized hospital (TASH)
Methods: This is a register based retrospective CAP study aimed to determine the magnitude of CAP treated at TASH over the last two years. Data was collected using a structured checklist. Data analysis was conducted by use of SPSS.
Result: A total of 104 Patients with clinically suspected and radiologically confirmed patients with CAP were included in the analysis. 55 (54%) were males. All of the patients had at least one co morbidity with CAP. CAP makes 1.19 % (104/8673) of all patients managed as in patient. Indication for admission by CURB-65 criteria was only 28% (29/104). On average patients were on IV antibiotics for 8 days with average LOS of 10.8 days before discharge.16 % were started on anti-TB. Most of them 97% (101/104) managed in the general wards and none of them were bacteremic. Sputum culture was done for only 8 %. 86 % (89/104) survived to discharge and 14 % (15/104) died in the hospital. 10.5% readmitted within 30 days.
Conclusion:This study demonstrated that only few of inpatient managed cases were due to CAP. The main indication for admission was presence of comorbidity. This is a baseline study that could be used for further prospective study to characterize all aspects of CAP in TASH.
1. C. Feldman, A. J. Brink, G. A. Richards, G. Maartens, and E. D.Bateman, “South African guideline for the management of community acquired pneumonia in adults,” South African Thoracic Society, Federation of Infectious Diseases Societies of Southern Africa, vol. 9(6), pp.1469-1502, 2017.
2. T. M. File Jr. and T. J. Marrie, “Burden of community-acquired Pneumonia in North American adults,” Postgraduate Medicine, vol. 122, no. 2, pp. 130–141, 2010.
3. R. E. Isturiz,C.M. Luna, and J. Ramirez, “Clinical and economic burden of pneumonia among adults in Latin America,” International Journal of Infectious Diseases, vol. 14, no. 10, pp.e852–e856, 2010.
4. J.-H. Song, V. Thamlikitkul, and P.-R. Hsueh, “Clinical and economic burden of community-acquired pneumonia amongst adults in the Asia-Pacific region,” International Journal of Antimicrobial Agents, vol. 38, no. 2, pp. 108–117, 2011.
5. T. Welte, “Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 31, no. 1, pp. 33–47, 2012.
6. T. Welte, A. Torres, and D. Nathwani, “Clinical and economic burden of community-acquired pneumonia among adults in Europe,” Thorax, vol. 67, no. 1, pp. 71–79, 2012
7. J. S. Brown, “Community-acquired pneumonia,” Clinical Medicine, vol. 12, no. 6, pp. 538–543, 2012
8. H J Zar,S A Madhi,S J Aston, S B Gordon Pneumonia in low and middle income countries: progress and challenges
9. Scott JAG, Adegbola R, Gordon S. Pneumonia in adults. In: Mabey D, Gill G,Weber MW, et al, eds. Principles of medicine in Africa. 4thedn. Cambridge: Cambridge University Press, 2012:264–76.
10. F. Blasi,M.Mantero, S. Pier Achille, and P. Tarsia, “Understanding the burden of pneumococcal disease in adults,” Clinical Microbiology and Infections, vol. 18, supplement 5,pp. 7–14, 2012
11. C. Feldman and R. Anderson, “Cigarette smoking and mechanisms of susceptibility to infections of the respiratory tract and other organ systems,” Journal of Infection, vol. 67, no. 3, pp. 169– 184, 2003.
12. F. Sanz Herrero and J. Blanquer Olivas, “Microbiology and risk factors for community-acquired pneumonia,” Seminars in Respiratory and Critical Care Medicine, vol. 33, no. 3, pp. 220–231, 2012.
13. G. Madeddu, M. Laura Fiori, and M. Stella Mura, “Bacterial community-acquired pneumonia in HIV-infected patients,”Current Opinion in Pulmonary Medicine, vol. 16, no. 3, pp. 201–207, 2010.
14. C. Feldman, K. P. Klugman, V. L. Yu et al., “Bacteremic pneumococcal pneumonia: impact of HIV on clinical presentation and outcome,” Journal of Infection, vol. 55, no. 2, pp. 125–135,2007.
15. C. Feldman and R. Anderson, “HIV-associated bacterial pneumonia, “Clinics in Chest Medicine, vol. 34, no. 2, pp. 205–216,2013.
16. I. Martin-Loeches, J. Sol´e-Viol´an, F. Rodr´ıguez de Castro et al.,“Variants at the promoter of the interleukin-6 gene are associated with severity and outcome of pneumococcal communityacquired pneumonia,” Intensive CareMedicine, vol. 38,no. 2, pp.256–262, 2012.
17. M. K. Dahmer, P. O’Cain, P. P. Patwari et al., “The influence of genetic variation in surfactant protein B on severe lung injury in African American children,” Critical Care Medicine, vol. 39, no. 5, pp. 1138–1144, 2011.
18. M. I. Garc´ıa-Laorden, F. Rodr´ıguez de Castro, J. Sol´e-Viol´anetal., “Influence of genetic variability at the surfactant proteins A and D in community-acquired pneumonia: a prospective, observational, genetic study,” Critical Care, vol. 15, no. 1, article R57, 2011.
19. Haftu Berhe Gebru. Magnitude of Community Acquired Pneumonia among Hospital Treated Adults in Tigray, Ethiopia: A Hospital Based Retrospective Study: Journal of Health, Medicine and Nursing, An International Peer-reviewed Journal Vol.33, 2016
20. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community acquired pneumonia in adults. Clin Infect Dis.2007; 44:S27–S72.
21. Bigelow B, Desalegn DN, Salomon JA, et al. modelling hospital operations: insight from using data from paper registries in the obstetrics ward at a hospital in Addis Ababa, Ethiopia. BMJ Glob Health 2019;4:e001281. doi:10.1136/ bmjgh-2018-001281
22. Federal Democratic Republic of Ethiopia of Health Ministry: communicable diseases part one,2011
23. J. M. Pereira, J. A. Paiva, and J. Rello, “Assessing severity of patients with community-acquired pneumonia,” Seminars in Respiratory and Critical Care Medicine, vol. 33, no. 3, pp. 272–283, 2012.
24. Joshua P. Metlay*, Grant W. Waterer*, Ann C. Long, Antonio Anzueto, Jan Brozek, Kristina Crothers, Laura A. Cooley,Nathan C. Dean, Michael J. Fine, Scott A. Flanders, Marie R. Griffin, Mark L. Metersky, Daniel M. Musher,Marcos I. Restrepo, and Cynthia G. Whitney; IDSA/ATS,Diagnosis and Treatment of Adults with Community-acquired Pneumonia AUGUST 2019
25. Aderaye G., The Etiology of Community Acquired Pneumonia in Adults in Addis Ababa;West Africa Journal of Medicine 1994 jul-sep:13(3):142-5
26. MANDELL, DOUGLAS, AND BENNETT’S PRINCIPLES AND PRACTICE OF INFECTIOUS DISEASES, NINTH EDITION,2020
27. Craven DE. Blood cultures for community-acquired pneumonia: piecing together a mosaic for doing less. Am J Respir Crit Care Med. 2004; 169:327–328.
28. Temesgen et al. Antimicrobial Resistance and Infection Control (2019) 8:101
Bacteriology of community acquired pneumonia in adult patients at Felege Hiwot Referral Hospital, Northwest Ethiopia: a cross-sectional study